VICODIN ES Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vicodin Es, and what generic alternatives are available?
Vicodin Es is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in VICODIN ES is acetaminophen; hydrocodone bitartrate. There are sixty-six drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.
Summary for VICODIN ES
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Clinical Trials: | 37 |
Patent Applications: | 464 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for VICODIN ES |
DailyMed Link: | VICODIN ES at DailyMed |
Recent Clinical Trials for VICODIN ES
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Weill Medical College of Cornell University | Phase 4 |
Boston University | Phase 4 |
Antonios Likourezos | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for VICODIN ES
US Patents and Regulatory Information for VICODIN ES
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | VICODIN ES | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 089736-001 | Dec 9, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |